Stress in Meth Study

Home
United States
Little Rock, AR
Stress in Meth Study

Not currently enrolling Up to 20 methamphetamine-using participants between the ages of 21 and 55 years old will be part of this study.

The purpose of this study is to learn more about how people who use methamphetamine respond to stressful events, such as being in an emergency department (ED) setting. By doing this study, we also hope to find out whether certain tasks make a space at UAMS that looks like an ED seem more like an actual ED. This is not a treatment study. This study involves three 3-hour visits to UAMS, including an in-person screening session and two laboratory day sessions. At the first laboratory day session, participants will be asked to either respond to three different scenarios or to imagine the circumstances surrounding their most stressful visit to an emergency department. Participants will then be asked to complete a simple arithmetic task. At the second laboratory day session, participants will be asked to watch a nature video instead of completing a speaking task and an arithmetic task. There is no cost to participate in this study and participants will be compensated for their time. Eligibility Criteria:

Male or female
Ages 21-55
Have been previously inside an ED as either a patient or visitor
Recent history of methamphetamine use
Able to attend three 3-hour visits to UAMS
This study is currently accepting participants. For more information, e-mail Dr. Michael Wilson at MPWilson@uams.edu or contact the DEMBER Lab at (501) 570-6362. All calls are confidential.

09/28/2023

https://news.uams.edu/2023/09/27/uams-arkansas-childrens-baptist-health-and-proton-international-open-states-first-proton-center/

The Proton Center of Arkansas opened today at the University of Arkansas for Medical Sciences (UAMS), becoming the first proton therapy center in Arkansas and only the 43rd in the nation to provide the most advanced cancer radiation treatment in the world. Proton therapy is a cutting-edge form of ra...

09/14/2023

https://www.npr.org/sections/health-shots/2023/09/14/1199396794/fentanyl-mixed-with-co***ne-or-m**h-is-driving-the-4th-wave-of-the-overdose-cris

A new study finds a 50-fold growth in deaths from combined use of stimulants and opioids. The toxic and contaminated drug supply is to blame.

08/31/2023

Call 501-570-6362 to learn more. All calls are confidential.

08/30/2023

https://www.cnn.com/2023/08/30/health/narcan-over-the-counter/index.html

The first over-the-counter naloxone, a drug used to reverse opioid overdose, will be available in retail stores and online as soon as next week, its manufacturer said Wednesday.

08/16/2023

https://www.cnn.com/2023/08/15/health/drug-alcohol-addiction-kff-poll/index.html

The drug epidemic has become deadlier than ever in the United States in recent years, and a new poll from KFF captures the significant toll that substance use has had on families nationwide.

06/09/2023

https://www.justice.gov/archive/olp/m**hawareness/

M**hamphetamine abuse has become a tremendous challenge for the entire Nation. Education, prevention, and community involvement are key parts of our National Strategy to reduce the demand for m**h. People who know about the destructive effects of m**h on the user and the community, are far less like...

06/07/2023

The clinic is June 16 from 8 a.m. to 4 p.m. at Freeway Medical Tower, 5800 W. 10th St., Suite 501. https://bit.ly/42plbia

05/25/2023

M**hamphetamine (MAMP) use, distribution and manufacture remain a serious public health and safety problem in the United States, and children environmentally exposed to MAMP face a myriad of developmental, social and health risks, including severe abuse ...

05/18/2023

Listen to this episode from Wonks at Work on Spotify. Harm reduction is a key part of how we address the opioid epidemic. Making the overdose-reversal drug naloxone more widely available is a mainstay of harm reduction and the chief objective of ACHI's NaloxHome program. It is also critical to c***e...

05/16/2023

Drug overdose deaths in Arkansas reached new heights during the COVID-19 pandemic, with illicitly manufactured fentanyl and other synthetic opioids contributing to the increase, ACHI President and CEO Dr. Joe Thompson says in a new interview with radio station KUAF.

05/05/2023

Happy Nurses Week to our wonderful ED nurses!

Address

Little Rock, AR
72205

Telephone

+15015706362

Website

http://uams.info/meth

Alerts

Be the first to know and let us send you an email when Stress in Meth Study posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Stress in Meth Study:

Shortcuts

Featured

Devon Davasher, LCSW
72207

Want your practice to be the top-listed Clinic in Little Rock?

About us:

We are seeking m**hamphetamine users who are not currently trying to find treatment for a UAMS research study about how people respond to stress in the emergency department.

What’s involved:

Three 3-hour visits to UAMS

Who: